Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
Medicine|April 9, 2021
Immune-related adverse events with immune checkpoint inhibitors: Special reference to the effects on the lungsAya Hirata, Takeshi Saraya, Fumi Kobayashi, et al.
Journal of Clinical Medicine|October 16, 2024
Clinical Evaluation of Acute Exacerbation of Interstitial Lung Disease in a Single Tertiary Center: Perspectives before and after the Coronavirus Disease 2019 PandemicRyo Takagi, Takeshi Saraya, Sho Yamada, et al.
Thoracic Cancer|November 28, 2023
Extended ICI treatment after first-line chemoimmunotherapy could predict the clinical benefit of ramucirumab plus docetaxel in advanced non-small lung cancer: Post hoc analysis from NEJ051 (REACTIVE study)Ou Yamaguchi, Keita Mori, Saori Takata, et al.
Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG|October 21, 2016
Clinical significance of the "galaxy sign" in patients with pulmonary sarcoidosis in a Japanese single-center cohortTakashi Koide, Takeshi Saraya, Yayoi Tsukahara, et al.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|August 23, 2011
Kinetics of c-reactive protein (CRP) and serum amyloid A protein (SAA) in patients with community-acquired pneumonia (CAP), as presented with biologic half-life timesSaori Takata, Hiroo Wada, Masaki Tamura, et al.
Journal of Clinical Medicine|October 16, 2024
Serum Derivatives-Reactive Oxygen Metabolite Levels as a Marker of Clinical Conditions in Patients with Bronchial Asthma, COPD, or Asthma-COPD Overlap: A Prospective StudyKeitaro Nakamoto, Masato Watanabe, Masaoki Saito, et al.
Journal of Clinical Medicine|February 13, 2025
Predictors of Severe Coughing and Its Impact on Bronchoalveolar Lavage and Transbronchial Lung Biopsy in Patients with Diffuse Lung Disease: Evaluation of Bronchoscopy SafetyFumi Kobayashi, Takeshi Saraya, Nozomi Kurokawa, et al.
BMC Cancer|May 28, 2017
Phase I/II study of induction chemotherapy using carboplatin plus irinotecan and sequential thoracic radiotherapy (TRT) for elderly patients with limited-disease small-cell lung cancer (LD-SCLC): TORG 0604Yuki Misumi, Hiroaki Okamoto, Jiichiro Sasaki, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 2, 2024
Phase II Study of Durvalumab Immediately after Completion of Chemoradiotherapy in Unresectable Stage III Non-small Cell Lung Cancer: TORG1937 (DATE Study)Shinji Nakamichi, Kaoru Kubota, Toshihiro Misumi, et al.
Respiratory Investigation|July 31, 2026
Clinical predictors of severe cough and desaturation during endobronchial ultrasound-guided transbronchial needle aspirationFumi Kobayashi, Takeshi Saraya, Nozomi Kurokawa, et al.
Pageof 4